TABLE 1.
Clinical baseline characteristics of patients with familial aggregation of HBV patients.
| Characteristics | Non‐liver cancer (n = 1020) | Liver cancer (n = 265) | p |
|---|---|---|---|
| Male (%) | 701 (68.7) | 206 (77.7) | 0.015 |
| Age (mean ± SD) | 51.70 ± 11.28 | 50.35 ± 10.91 | 0.131 |
| Hb (mean ± SD) | 125.71 ± 30.88 | 135.24 ± 29.00 | < 0.001 |
| NP (mean ± SD) | 61.58 ± 13.15 | 66.35 ± 11.00 | < 0.001 |
| TP (mean ± SD) | 65.52 ± 13.07 | 67.61 ± 13.63 | 0.022 |
| GGT (mean ± SD) | 74.06 ± 93.57 | 168.89 ± 185.56 | < 0.001 |
| AFU (mean ± SD) | 23.41 ± 9.32 | 30.02 ± 16.05 | < 0.001 |
| AAR (mean ± SD) | 1.25 ± 0.68 | 1.83 ± 2.11 | < 0.001 |
| AFP (mean ± SD) | 87.28 ± 197.08 | 604.12 ± 3141.99 | < 0.001 |
Abbreviations: AAR, aspartate aminotransferase (AST) to alanine aminotransferase (ALT) ratio; AFP, alpha‐fetoprotein; AFU, alglucosidase alfa; GGT, glutamyl transpeptidase; Hb, hemoglobin; NP, neutrophil percentage; SD, standard deviation; TP, total protein.